Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/25/1994 | US5358716 Pharmaceutical composition for topical application containing dithranol and preparation process |
10/25/1994 | US5358715 Molsidomine drug |
10/25/1994 | US5358706 Muco-adhesive polymers |
10/25/1994 | US5358502 PH-triggered osmotic bursting delivery devices |
10/25/1994 | CA1332765C Gelatine granules as well as methods and apparatus for their manufacture |
10/25/1994 | CA1332713C Skin penetration enhancement using free base and acid addition salt combinations of active agents |
10/25/1994 | CA1332712C Intravenous pharmaceutical composition |
10/23/1994 | CA2121723A1 Aqueous agent |
10/21/1994 | WO1994023710A1 Method of milking cows |
10/21/1994 | CA2138667A1 Method of milking cows |
10/20/1994 | DE4410476A1 Deodorizing lamp and method of manufacturing the same |
10/19/1994 | EP0620002A1 A solid pharmaceutical dosage form and a method for reducing abrasion |
10/19/1994 | EP0620001A1 Aqueous pharmaceutical suspension and process for preparation thereof |
10/19/1994 | EP0619802A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
10/19/1994 | EP0619741A1 Polar lipid composition of plant origin |
10/19/1994 | EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
10/19/1994 | EP0619735A1 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
10/19/1994 | EP0619733A1 System for delivering an active substance for sustained release |
10/19/1994 | EP0619731A1 Microcrystalline cellulose spheronization composition |
10/19/1994 | EP0619730A1 Composition of antineoplastic agents incorporated in micelles |
10/19/1994 | EP0619729A1 Composition to help stop smoking |
10/19/1994 | EP0546018B1 Pharmaceutical composition of florfenicol |
10/19/1994 | EP0449825B1 Improved emulsions of highly fluorinated organic compounds |
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/19/1994 | CN1093597A Release-controlled implantable somatotropin composition |
10/19/1994 | CN1093594A Medicine for curing tumour and preparation method thereof |
10/19/1994 | CN1093593A Pain-relieving antidiarrheal ointment |
10/19/1994 | CN1093592A Solid oral medicine for stomach trouble |
10/19/1994 | CN1093590A Brain-clearing spraying medicament for curing common cold |
10/19/1994 | CN1093583A Single equivalent Chinese medicine concentrated tablet capsule or medicine to be taken after being mixed with boiling water |
10/19/1994 | CN1093571A Parmaceutical agent |
10/18/1994 | US5356896 Alkaline stabiling medium |
10/18/1994 | US5356883 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
10/18/1994 | US5356636 Using mixture of oil soluble active material, film forming colloid and reducing sugar |
10/18/1994 | US5356635 Carbohydrate glass matrix for the sustained release of a therapeutic agent |
10/18/1994 | US5356634 Enteric coating containing cellulose acetate phthalate |
10/18/1994 | US5356633 Method of treatment of inflamed tissues |
10/18/1994 | US5356631 Pharmaceutical composition |
10/18/1994 | US5356630 Using an polyanhydride |
10/18/1994 | US5356625 Encapsulation with water soluble film; enteric coating of alkali-soluble acid-insoluble polymer |
10/18/1994 | US5356620 Aqueous solution containing polyvinylpyrrolidone, base, surfactant, preservative; topical treatment of allergic conjunctivitis or rhinitis |
10/18/1994 | US5356615 Antiplaque oral compositions |
10/18/1994 | US5356614 Process of preparing microparticulate collagen collagen-based products produced thereby and method of applying same |
10/18/1994 | US5356612 Mixing basic aluminum chloride with monosilicic acid in aqueous solution; drying to solid form |
10/18/1994 | US5356467 Controlled release coatings derived from aqueous dispersions of zein |
10/18/1994 | CA1332573C Chewing gum composition containing glycerol mono laurate |
10/18/1994 | CA1332570C Method for reducing skin irritation associated with drug/penetration enhancer compositions |
10/18/1994 | CA1332567C Sustained release pharmaceutical composition |
10/18/1994 | CA1332556C Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2-phenoxyethyl)-ammonium bromide and methods of using the same |
10/18/1994 | CA1332530C Sweet emulsion for chewing gum |
10/17/1994 | CA2119346A1 Solid pharmaceutical dosage form and a method for reducing abrasion |
10/14/1994 | WO1993019701A1 Angiogenic tissue implant systems and methods |
10/14/1994 | CA2132016A1 Angiogenic tissue implant systems and methods |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
10/13/1994 | WO1994022934A1 Random block copolymers |
10/13/1994 | WO1994022572A1 Method of encapsulating substances in biocapsules |
10/13/1994 | WO1994022481A1 Active-substance patch for releasing estradiol to the skin |
10/13/1994 | WO1994022480A1 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids |
10/13/1994 | WO1994022470A1 Factor xiii for treatment of skin wounds |
10/13/1994 | WO1994022468A1 Method for delivering beneficial compositions to hair follicles |
10/13/1994 | WO1994022461A1 Formulation for nasal insulin delivery |
10/13/1994 | WO1994022450A1 Nasal pharmaceutical composition containing a progestational agent |
10/13/1994 | WO1994022445A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
10/13/1994 | WO1994022441A2 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases |
10/13/1994 | WO1994022435A1 A new composition containing selegiline |
10/13/1994 | WO1994022434A1 RETARDED-ACTION MICROTABLET MADE OF β-PHENYLPROPIOPHENONE DERIVATIVES |
10/13/1994 | WO1994022432A1 Method of coating microporous membranes and resulting products |
10/13/1994 | WO1994022431A1 Controlled release preparation containing a salt of morphine |
10/13/1994 | WO1994022430A1 Method of producing liposomes |
10/13/1994 | WO1994022429A1 Solid-tumor treatment method |
10/13/1994 | WO1994022428A1 Method for reducing the induction of viruses using topically applied antioxidants |
10/13/1994 | WO1994022427A1 Method for preparing drugs to treat dermal disorders |
10/13/1994 | WO1994022426A1 Pharmaceutical composition containing lipophilic drugs |
10/13/1994 | WO1994022425A1 Anti-oxidant alkylaryl polyether alcohol polymers |
10/13/1994 | WO1994022424A1 Biodegradable, water-permeable membrane for fluid-imbibing pump |
10/13/1994 | WO1994022423A1 Drug administration system |
10/13/1994 | WO1994022422A1 Lidocaine aerosol anaesthetic |
10/13/1994 | WO1994022414A1 Multiple w/o/w emulsion preparation process |
10/13/1994 | WO1994022303A1 Coated microparticle agglomerates |
10/13/1994 | WO1994022302A1 Multiply-coated particles |
10/13/1994 | WO1994021240A3 Superparamagnetic particles, process for producing the same and their use |
10/13/1994 | WO1994017538A3 Microparticle switching devices |
10/13/1994 | DE4338999C1 Cold water-emulsifiable compositions |
10/13/1994 | CA2159646A1 Random block copolymers |
10/13/1994 | CA2159498A1 Method for preparing drugs to treat dermal disorders |
10/13/1994 | CA2159447A1 Use of cis-or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases |
10/13/1994 | CA2159209A1 Pharmaceutical composition containing lipophilic drugs |
10/13/1994 | CA2158951A1 Nasale pharmaceutical composition containing a progestagenic agent |
10/13/1994 | CA2156746A1 Active-substance patch for releasing estradiol to the skin |
10/12/1994 | EP0619322A2 Prolonged delivery of peptides |
10/12/1994 | EP0619119A1 Stabilized parathyroid hormone composition |
10/12/1994 | EP0619115A1 Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders |
10/12/1994 | EP0618808A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
10/12/1994 | EP0618807A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
10/12/1994 | EP0618806A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
10/12/1994 | EP0618795A1 Preparations containing a fluorocarbon emulsion and usable as cosmetics or dermatics |
10/12/1994 | EP0618791A1 Solid complex particles comprising a biologically active solid substance, mode of preparation and compositions for topical use containing them and intended to treat biological surfaces. |
10/12/1994 | EP0409870B1 Human growth hormone formulation |
10/12/1994 | EP0403578B1 Stable pharmaceutical composition |